genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Caffeine Could Help Fight Obesity
News
Gut Microbiome Changes Correlate with Non-Gut Pain
Tech Exclusives
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
News
Embryonic microRNA Labeled as Fountain of Youth for Heart Cells
News
CBD as a Next-Gen Antibiotic
Insights
Tech Exclusives
Turning Drug Delivery Inside Out
Insights
Sartorius Takes a Single-Use Approach to Derive Value from Biomanufacturing
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Tech Exclusives
Not If. When: Metabolomics’ Impact in Cancer Treatments May Be Just…
News
Type 1 Diabetes Risk Lower in Infants with Rotavirus Vaccination
A-Lists
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
Gene Therapy
25 Up-and-Coming Gene Therapies of 2019
June 2019 Vol. 39 No. 6
Top 10 Under 40 of 2019
Insights
Top 10 Best-Selling Cancer Drugs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Tech Exclusives
Turning Drug Delivery Inside Out
News
Gut Microbiome Changes Correlate with Non-Gut Pain
Tech Exclusives
PROTACs Developed with U. of Dundee Boost Boehringer Ingelheim’s Cancer Pipeline
News
CBD as a Next-Gen Antibiotic
Magazine
All
Supplement
Tech Exclusives
Fighting the Dangerous Increase of Multidrug-Resistant Microbes
Tech Exclusives
The Microbiome: Here, There, and Everywhere
Commentary
New Vaccine Expected to Play Major Role in Battle against Malaria
Commentary
Lipidomics Enriches Multiomics
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
A Web-Based Informatics Platform for PhysChem/ADME/Tox Property Predictions
GENcast
GENcast: Microbiome Research is More Than Just a Gut Reaction
Upcoming Webinars
Mind the Yap! Single-Cell Transcriptomes Reveal Drivers of Intestinal Regeneration
eBooks
Best Practices with an Agilent Parallel CE System
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Neurological Disorders
ALS
ALS
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
ALS
Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for Neurological, Inflammatory Diseases
ALS
Amyloids Shown to Also Play Beneficial Role in Developing Healthy Muscle Tissue
ALS
Axovant Licenses Benitec Gene Therapy Candidates for OPMD, Neurological Disorders
ALS
Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT
ALS
Neuraltus Weighs Future of Lead Candidate NP001 after Failure in Phase II ALS Trial
ALS
Biogen, Ionis Launch $1B+ Expanded Neuro Drug Partnership, following Spinraza Success
ALS
Novel Research Model Offers Hope to ALS and MS Patients
ALS
Hardening of the RNA Condensates May Solidify Neurodegeneration
ALS
Hope for ALS Patients Comes from New Understanding of RNA Metabolism...
ALS
CRISPR Screen Identifies Genetic Modifiers of ALS
ALS
CRISPR Human Knockout Screens Identify New Target for ALS
ALS
Studying Changing Neuron Size May Lead to New Therapies for Motor...
ALS
Proteomics Finding May Lead to Therapy Targeted at Cellular Pathway Linked...
ALS
Sangamo, Pfizer Partner on Gene Therapy for ALS, FTLD
ALS
Five Life Sciences Researchers Win Breakthrough Prizes Totaling $15M
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![The hnRNP A1B is expressed in the central nervous system and forms cytoplasmic aggregates in ALS patient neurons. [CRCHUM]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar19_2018_CRCHUM_hnRNPA1B2262381965-324x160.jpg "Hope for ALS Patients Comes from New Understanding of RNA Metabolism Misregulation")
![Flex Pharma cites unspecified “oral tolerability concerns” in halting Phase II trials of FLX-787 in amyotrophic lateral sclerosis (ALS) and Charcot-Marie-Tooth (CMT). [© whitehoune / Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/170123090806_1_900x6009916143062-265x198.jpg "Flex Pharma Axes 60% of Workforce, Explores Sale after Halting Phase II Trials in ALS, CMT")
